Endoscope public health advisory
This article was originally published in The Gray Sheet
Executive Summary
Inconsistencies between reprocessing instructions provided by an automated endoscope reprocessessor (AER) manufacturer and the maker of a reusable bronchoscope device apparently led to several incidents in which patients developed serious infections after undergoing a bronchoscope examination, FDA and the Centers for Disease Control and Prevention state in a Sept. 10 public health advisory. In addition, "bronchoscopes were inadequately reprocessed when inappropriate channel connectors were used with the AER," according to the statement
You may also be interested in...
Steris Corp.' s Complaint Handling System, QS Violations Cited By FDA
Steris Corporation failed to report or adequately determine the cause of several adverse events involving the Steris System 1 processor and Quick Connect Kit accessories, FDA contends in a Dec. 9 warning letter to the company.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.